Mihai Alexandru Pascu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mihai Alexandru Pascu has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Ionut Tanase
Department of Otorhinolaryngology, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania
2 shared publications - Alexandru Coman
“M. S. Curie” Emergency Clinical Hospital for Children, 077120 Bucharest, Romania
1 shared publication - Ari DeRowe
Department of Otolaryngology Head and Neck Surgery, Tel Aviv Sourasky University Medical Center, Gray Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv 6997801, Israel
1 shared publication - Codrut Sarafoleanu
Department of Otorhinolaryngology, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania
1 shared publication - Cristiana-Gratiela Oprea
ENT&HNS Department , “Maria Sklodowska Curie” Children’s Hospital , Bucharest , Romania
1 shared publication - Daniel Lupoi
ENT&HNS Department , “Sfanta Maria” Hospital , Bucharest , Romania
1 shared publication
Latest Publications
- Open Access
- 30 April 2026
- Published by Wiley in Otolaryngology–Head and Neck Surgery
Irreversible Electroporation for Tonsillar Ablation in Adults
Objective: To evaluate the safety and efficacy of irreversible electroporation for non‐thermal ablation of tonsils in adults. Study Design: Prospective interventional case series of 24 adult patients referred for tonsillectomy that were followed for 3 months. Setting: Academic medical center. Methods: The procedures were performed under general anesthesia or sedation. Irreversible electroporation was applied to the tonsils using the ENTire TM system. Pain was assessed daily using a pain scale for the first postoperative week. Tonsil sizes were assessed at baseline and 1 and 3 months postoperatively. The Tonsil and Adenoid Health Status Instrument and the Snore‐Visual Analog Scale (VAS) questionnaires were administered at baseline and at 3 months. Results: In total, 23 adult patients (mean age: 36.5 ± 14.0; mean body mass index [BMI]: 25.5 ± 4.1) completed the study. No bleeding was observed intra‐ or postoperatively. Procedural time was 7.98 ± 2.62 minutes. A pain scale score below 2 was reported 4.5 ± 1.7 days after intervention. Reduction in tonsillar size was observed from 2.4 ± 0.9 pre‐intervention to 1.3 ± 1.0 at 3 months post‐intervention ( P < .001). Tonsil and Adenoid Health Status scores decreased from 17.7 ± 13.0 to 0.96 ± 1.7 ( P < .001). The Snore‐ VAS score decreased by 72%. Conclusion: This is the first clinical study to investigate the use of irreversible electroporation for tonsillar ablation. Irreversible electroporation shows promise as a minimally invasive procedure for reducing the size of tonsillar hypertrophy and alleviating symptoms, with negligible bleeding and significantly less pain. Multicenter studies are in progress to evaluate long‐term efficacy including in children.
- 30 April 2026
- Published by Wiley in Otolaryngology–Head and Neck Surgery
Open AccessIrreversible Electroporation for Tonsillar Ablation in Adults
Objective: To evaluate the safety and efficacy of irreversible electroporation for non‐thermal ablation of tonsils in adults. Study Design: Prospective interventional case series of 24 adult patients referred for tonsillectomy that were followed for 3 months. Setting: Academic medical center. Methods: The procedures were performed under general anesthesia or sedation. Irreversible electroporation was applied to the tonsils using the ENTire TM system. Pain was assessed daily using a pain scale for the first postoperative week. Tonsil sizes were assessed at baseline and 1 and 3 months postoperatively. The Tonsil and Adenoid Health Status Instrument and the Snore‐Visual Analog Scale (VAS) questionnaires were administered at baseline and at 3 months. Results: In total, 23 adult patients (mean age: 36.5 ± 14.0; mean body mass index [BMI]: 25.5 ± 4.1) completed the study. No bleeding was observed intra‐ or postoperatively. Procedural time was 7.98 ± 2.62 minutes. A pain scale score below 2 was reported 4.5 ± 1.7 days after intervention. Reduction in tonsillar size was observed from 2.4 ± 0.9 pre‐intervention to 1.3 ± 1.0 at 3 months post‐intervention ( P < .001). Tonsil and Adenoid Health Status scores decreased from 17.7 ± 13.0 to 0.96 ± 1.7 ( P < .001). The Snore‐ VAS score decreased by 72%. Conclusion: This is the first clinical study to investigate the use of irreversible electroporation for tonsillar ablation. Irreversible electroporation shows promise as a minimally invasive procedure for reducing the size of tonsillar hypertrophy and alleviating symptoms, with negligible bleeding and significantly less pain. Multicenter studies are in progress to evaluate long‐term efficacy including in children.
- Open Access
- 28 February 2025
- Published by Walter de Gruyter GmbH in Romanian Journal of Rhinology
- Vol. 15 (57) , 21-25
Choanal atresia: comprehensive review of diagnosis and management
Choanal atresia is a congenital condition characterized by the obstruction of the posterior nasal apertures. It can present as unilateral or bilateral and is associated with significant morbidity, particularly in neonates. This review provides a comprehensive overview of the diagnosis and management of choanal atresia. We discuss the epidemiology, etiology, and pathogenesis, emphasizing the developmental and genetic factors involved. Clinical presentation varies with age, and diagnosis typically involves a combination of clinical examination and imaging techniques. Management strategies have evolved, with a focus on surgical intervention. Various surgical techniques, including transnasal endoscopic and transpalatal approaches, are explored. Postoperative care and long-term outcomes are critical components of patient management. We also address current controversies in treatment and future directions for research. Understanding choanal atresia’s complexities is essential for improving patient outcomes and advancing therapeutic options.
- 28 February 2025
- Published by Walter de Gruyter GmbH in Romanian Journal of Rhinology
- Vol. 15 (57) , 21-25
Open AccessChoanal atresia: comprehensive review of diagnosis and management
Choanal atresia is a congenital condition characterized by the obstruction of the posterior nasal apertures. It can present as unilateral or bilateral and is associated with significant morbidity, particularly in neonates. This review provides a comprehensive overview of the diagnosis and management of choanal atresia. We discuss the epidemiology, etiology, and pathogenesis, emphasizing the developmental and genetic factors involved. Clinical presentation varies with age, and diagnosis typically involves a combination of clinical examination and imaging techniques. Management strategies have evolved, with a focus on surgical intervention. Various surgical techniques, including transnasal endoscopic and transpalatal approaches, are explored. Postoperative care and long-term outcomes are critical components of patient management. We also address current controversies in treatment and future directions for research. Understanding choanal atresia’s complexities is essential for improving patient outcomes and advancing therapeutic options.